(R) -Zunsemetinib
Selected Variant
HY-139553A-01
Size: 1 mg
(R) -Zunsemetinib is the isomer of Zunsemetinib , and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1].
Product Specifications
CAS Number
1640282-44-5
Product Name Alternative
(R) -ATI-450; (R) -CDD-450
UNSPSC
12352005
Target
Drug Isomer
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/r-zunsemetinib.html
Purity
97.84
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
FC1=CC(F)=CN=C1COC2=C(Cl)C(N(C3=CC(C4=NC(C(C)(C)O)=NC=C4)=NC=C3C)C(C)=C2)=O
Molecular Formula
C25H22ClF2N5O3
Molecular Weight
513.92
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Gastrin (GAST/2635), CF488A conjugate, 0.1mg/mL
MUC18 / Mucin 18 / CD146 (MUC18/1130), CF568 conjugate, 0.1mg/mL
CD86 (C86/1146), CF488A conjugate, 0.1mg/mL
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (BCL2/2210R), CF647 conjugate, 0.1mg/mL
